Brief: Biohit: modern colorectal cancer screening test on the market from Finland
12/05/2015 07:30
May 12 (Reuters) - Biohit Oyj BIOBV.HE :
* Says Colonview was superior to conventional fecal occult blood (FOB) test
in colorectal cancer screening due to its significantly higher sensitivity and
specificity
Source text for Eikon: ID:nHSU5QM1
Further company coverage: BIOBV.HE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))